Drew Monitto is an Oncology physician affiliated with University of South Carolina Upstate. OpenAlex indexes 10 publications with 566 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
49.1%alpha-Adrenergic Blocker43.9%Tamsulosin Hcl100%Part D≥86 patientsCholinergic Muscarinic Antagonist3.1%Oxybutynin Chloride Er100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
29.7%Androgen Receptor Inhibitor22.2%Bicalutamide100%Part D≥53 patientsGonadotropin Releasing Hormone Receptor Antagonist7.5%Orgovyx100%Part D≥13 patientsSensory organs
14.2%Fluoroquinolone Antibacterial11.2%Ciprofloxacin Hcl100%Part D≥72 patientsCorticosteroid3%Dexamethasone100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Primary Endpoint Analysis of a Randomized Phase III Trial of Hypofractionated vs. Conventional Post-Prostatectomy Radiotherapy: NRG Oncology GU003
International Journal of Radiation Oncology*Biology*Physics
2021
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”